The
In the Pipeline blog references an article about
Addex Therapeutics changing focus to their clinical pipeline. More details on their
press release. I've talked about
Addex before, they are located close to Geneva and are developing allosteric modulators as drugs. One thing they talk about is reducing their cost structure including layoffs in their early development stage.